Seelos Therapeutics Inc (SEEL) concluded trading on Wednesday at a closing price of $0.73, with 15.5 million shares of worth about $11.32 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -93.65% during that period and on July 10, 2024 the price saw a gain of about 6.84%. Currently the company’s common shares owned by public are about 2.86M shares, out of which, 2.69M shares are available for trading.
Stock saw a price change of 25.26% in past 5 days and over the past one month there was a price change of -32.10%. Year-to-date (YTD), SEEL shares are showing a performance of -93.47% which decreased to -99.75% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.47 but also hit the highest price of $398.40 during that period. The average intraday trading volume for Seelos Therapeutics Inc shares is 171.67K. The stock is currently trading -0.69% below its 20-day simple moving average (SMA20), while that difference is down -47.92% for SMA50 and it goes to -94.95% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Seelos Therapeutics Inc (NASDAQ: SEEL) currently have 2.86M outstanding shares and institutions hold larger chunk of about 11.48% of that.
The stock has a current market capitalization of $2.08M and its 3Y-monthly beta is at 1.90. It has posted earnings per share of -$42.75 in the same period. It has Quick Ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SEEL, volatility over the week remained 23.78% while standing at 15.64% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by ROTH Capital on September 27, 2021 offering a Buy rating for the stock and assigned a target price range of between $2.50 and $8 to it. Coverage by Guggenheim stated Seelos Therapeutics Inc (SEEL) stock as a Buy in their note to investors on July 01, 2021, suggesting a price target of $8 for the stock. Stock get a Buy rating from B. Riley Securities on March 30, 2021.
